Curaleaf Holdings Inc CURLF

Primary Symbol: T.CURA

Healthcare Cannabis

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

TSX:CURA - Post by User

Curaleaf Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Saxmanon Sep 15, 2024 9:05am

87 Views

Post# 36224313

Germany

Market Insights Health Cannabis

Medical Cannabis - Germany

Germany

Germany is expected to see a projected revenue of US$499.80m in the Medical Cannabis market market by 2024.
The revenue is forecasted to exhibit a CAGR of 3.54% between 2024 and 2029, leading to a market volume of US$594.80m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue in 2024, amounting to US$14,530.00m.
In terms of per person revenues in 2024, US$1.51k are generated based on total population figures.
Germany's Medical Cannabis market is rapidly expanding, with increasing patient access and growing acceptance of its therapeutic benefits.